Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001276071 | SCV001685581 | likely benign | Tay-Sachs disease | 2024-12-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372436 | SCV002688522 | likely benign | Inborn genetic diseases | 2021-12-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001276071 | SCV001461908 | uncertain significance | Tay-Sachs disease | 2019-01-06 | no assertion criteria provided | clinical testing |